NCT03761212 (FoLoMI) is a clinical trial in Ankylosing Spondylitis, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT03761212?

NCT03761212 is sponsored by University Hospital, Grenoble.

What condition does NCT03761212 study?

NCT03761212 studies Ankylosing Spondylitis.

Is NCT03761212 still recruiting?

NCT03761212 is currently completed. Last updated 23 November 2022.

Last reviewed 2022-11-23 · How we verify

NCT03761212: FoLoMI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Function, Locomotion, Measurement and Inflammation

Completed Last updated 23 November 2022

What this trial tests

trial in Ankylosing Spondylitis in 90 participants. Completed in 10 February 2022.

Timeline

13 August 2018

Primary endpoint
10 February 2022

10 February 2022

Quick facts

Lead sponsor	University Hospital, Grenoble
Status	Completed
Study type	OBSERVATIONAL
Enrollment	90
Start date	13 August 2018
Primary completion	10 February 2022
Estimated completion	10 February 2022
Sites	1 location across France

Conditions studied

Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →

Sponsor

University Hospital, Grenoble

Who can join

Adults 18 to 65, any sex, with Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

FoLoMI is a pilot study in which the investigators will seek to determine if gait spatio-temporal and kinematic parameters can explain the evolution of a functional score, the Bath Ankylosing Spondylitis Functional Index (BASFI), at 18 months. The secondary objectives are: (1) to study the relationship between gait parameters measured at T0 and the BASFI at T0, (2) to study the relationship between gait parameters at T0 and the BASDAI at T0, (3) to assess general state of health of the patients and its evolution by appreciating: level of physical activity, state of fatigue, diurnal sleepiness and quality of life, and (4) to compare spatio-temporal gait parameters between patients and healthy controls.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Spatio-temporal gait parameters obtained from foot-worn inertial sensors are reliable in healthy adults in single- and dual-task conditions.
Soulard J, Vaillant J, Balaguier R, Vuillerme N. · · 2021 · cited 28× · PMID 33986307 · DOI 10.1038/s41598-021-88794-4
Foot-Worn Inertial Sensors Are Reliable to Assess Spatiotemporal Gait Parameters in Axial Spondyloarthritis under Single and Dual Task Walking in Axial Spondyloarthritis.
Soulard J, Vaillant J, Balaguier R, Baillet A, et al · · 2020 · cited 11× · PMID 33198119 · DOI 10.3390/s20226453
Gait and Axial Spondyloarthritis: Comparative Gait Analysis Study Using Foot-Worn Inertial Sensors.
Soulard J, Vaillant J, Baillet A, Gaudin P, et al · · 2021 · cited 8× · PMID 34751663 · DOI 10.2196/27087
Gait as predictor of physical function in axial spondyloarthritis: the prospective longitudinal FOLOMI (Function, Locomotion, Measurement, Inflammation) study protocol.
Soulard J, Vuillerme N, Gaudin P, Grange L, et al · · 2019 · cited 8× · PMID 31392500 · DOI 10.1007/s00296-019-04396-4
The effects of a secondary task on gait in axial spondyloarthritis.
Soulard J, Vaillant J, Baillet A, Gaudin P, et al · · 2021 · cited 2× · PMID 34599222 · DOI 10.1038/s41598-021-98732-z

Verify or expand the search:

Other recruiting trials for Ankylosing Spondylitis

Currently open trials in the same condition.

NCT07510789 — Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis · recruiting
NCT07261644 — A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) · Phase 3 · recruiting
NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
NCT06905288 — Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. · recruiting
NCT07166874 — The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis · NA · recruiting

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03761212 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 23 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03761212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing